Physician profile
Mark E Wuchner
NPI 1861594335
$417.65
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $31.58 · 2021: $60.15 · 2022: $62.02 · 2023: $19.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $69.76 | 2019-2022 | |
| Pfizer INC. | $61.13 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $42.27 | 2019 | |
| Astellas Pharma US INC | $34.89 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $30.74 | 2020-2022 | |
| Amarin Pharma, INC. | $29.44 | 2019-2020 | |
| Gilead Sciences, INC. | $24.77 | 2021 | |
| Glaxosmithkline, LLC. | $19.23 | 2023 | Shingrix |
| Antares Pharma, INC. | $18.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2021 | |
| Amgen INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wuchner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.